Solid pharmaceutical tablet
US-2024226038-A9 · Jul 11, 2024 · US
Controlled release hydrocodone formulations
US8980291B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980291-B2 |
| Application number | US-98238610-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 30, 2010 |
| Priority date | Oct 29, 1999 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C 12 /C max ratio of 0.55 to 0.85, said dosage form providing a therapeutic effect for at least about 12 hours.
First claim
Opening claim text (preview).
We claim: 1. A solid oral twice-a-day controlled-release dosage form, wherein the dosage form is a tablet consisting of (i) a plurality of individually coated multiparticulates consisting of matrices individually coated with a coating consisting of ethylcellulose and a wax, the matrices collectively consisting of from about 5 mg to about 60 mg hydrocodone or an equivalent amount of a pharmaceutically acceptable salt thereof, hydroxypropylmethyl cellulose and ethylcellulose, (i…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K31/485Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8980291B2 cover?
- A solid oral controlled-release oral dosage form of hydrocodone is disclosed. The dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and a sufficient amount of a controlled release material to render the dosage form suitable for twice-a-day administration to a human patient, the dosage form providing a C 12 /C max ratio of 0.5…
- Who is the assignee on this patent?
- Oshlack Benjamin, Huang Hua-Pin, Masselink John, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/485. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).